| Ontology | CARD's Antibiotic Resistance Ontology |
| Accession | ARO:3007516 |
| Definition | Clotrimazole is a type of imidazole antibiotic, particularly antifungal. It is mostly used for the treatment of tinea pedis, vulvovaginal and oropharyngeal candidiasis. It has broad activity against Candida albicans and other fungal infections. |
| SMILES | Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 |
| PubChem | 2812 |
| CHEBI | 3764 |
| CAS | 23593-75-1 |
| ChEMBL | CHEMBL104 |
| Drug Class | azole antibiotic, imidazole antibiotic |
| Classification | 3 ontology terms | Show |
| Parent Term(s) | 1 ontology terms | Show + imidazole antibiotic [Drug Class] |
| Sub-Term(s) | 4 ontology terms | Show + Candida tropicalis Erg11 lanosterol 14-alpha-demethylase with mutations conferring resistance to clotrimazole confers_resistance_to_antibiotic + Saccharomyces cerevisiae ATP1 with mutations conferring resistance to clotrimazole confers_resistance_to_antibiotic + Saccharomyces cerevisiae ATP2 with mutations conferring resistance to clotrimazole confers_resistance_to_antibiotic + Candida albicans Erg11 with mutations conferring resistance to clotrimazole confers_resistance_to_antibiotic |
| Publications | Marget W, et al. 1971. Acta Paediatr Scand 60(3):341-5 Bay B 5097, a new orally applicable antifungal substance with broadspectrum activity. Preliminary clinical and laboratory experiences in children. (PMID 5579860) Burgess MA, et al. 1972. Antimicrob Agents Chemother 2(6):423-6 Clotrimazole (Bay b 5097): in vitro and clinical pharmacological studies. (PMID 4677595) |
| Curator | Description | Most Recent Edit |
|---|